Gregory Cosgrove

Company: Pliant Therapeutics Inc.

Job title: VP Clinical Development

Seminars:

Examining the Phase 2b BEACON-IPF Trial of Bexotegrast for Patients with IPF 8:00 am

• Exploring key study design and attributes of the phase 2b trial • Exploring the selected clinical study design including patient populations, biomarker panel, endpoint selection and beyond • Looking on to the phase 3 study, what is next? Read more

day: Day One